Mucostar (Carbocisteine)

Carbocisteine works by breaking disulfide bonds within mucoproteins, which reduces the viscosity and elasticity of sputum. This chemical alteration transforms thick, sticky mucus into a more fluid form that can be more easily expelled by coughing or ciliary action, thereby enhancing airway patency.

The appropriate dose of Mucostar is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and specific respiratory condition. Patients should follow the exact dosage instructions provided by their clinician and not adjust the dose on their own.

Safety data for carbocisteine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before starting Mucostar. The prescriber will weigh the therapeutic need against any possible fetal or infant exposure.

To order Mucostar, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Carbocisteine, the active ingredient in Mucostar, primarily reduces mucus viscosity by cleaving disulfide bonds, whereas other mucolytics like N‑acetylcysteine act as antioxidants and may have additional mucolytic mechanisms. The choice between agents depends on clinical judgment, patient tolerance, and specific therapeutic goals.

Mucostar should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity, which could affect its stability and efficacy.

Mucostar is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing clinician’s instructions regarding timing relative to meals to minimize gastrointestinal discomfort.

Serious but rare risks include severe allergic reactions such as anaphylaxis, significant gastrointestinal bleeding, and hepatic dysfunction. Patients should seek immediate medical attention if they experience symptoms like swelling of the face or throat, persistent vomiting blood, or jaundice.

Mucostar is contraindicated in individuals with known hypersensitivity to carbocisteine or any excipients in the formulation. Patients with uncontrolled asthma exacerbations, severe renal impairment without dose adjustment, or those taking medications that may cause dangerous interactions should avoid using it unless directed by a physician.